Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol. - sprookjes - yvandenbroek - TriplyDB

Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.

Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.

http://www.wikidata.org/entity/Q33359381

about

Interaction of Isoflavones with the BCRP/ABCG2 Drug Transporter Dose-dependent effects of genistein on bone homeostasis in rats' mandibular subchondral bone.Plum and soy aglycon extracts superior at increasing bone calcium retention in ovariectomized Sprague Dawley rats Combined treatment of isoflavone supplementation and exercise restores the changes in hepatic protein expression in ovariectomized rats - a proteomics approach Genistein aglycone improves skin repair in an incisional model of wound healing: a comparison with raloxifene and oestradiol in ovariectomized rats.A longitudinal study of the effect of genistein on bone in two different murine models of diminished estrogen-producing capacity Histological investigation of the effect of soybean (Glycine max) extracts on the collagen layer and estrogen receptors in the skin of female rats.Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women.Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms Genistein, a phytoestrogen, improves total cholesterol, and Synergy, a prebiotic, improves calcium utilization, but there were no synergistic effects.Current knowledge and future direction of research on soy isoflavones as a therapeutic agents The bone-protective effect of genistein in the animal model of bilateral ovariectomy: roles of phytoestrogens and PTH/PTHR1 against post-menopausal osteoporosis.Genistein aglycone, a soy-derived isoflavone, improves skin changes induced by ovariectomy in rats.Potential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.Effects of Extracts from Trifolium medium L. and Trifolium pratense L. on Development of Estrogen Deficiency-Induced Osteoporosis in Rats.Genistein treatment increases bone mass in obese, hyperglycemic mice Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter Effect of formononetin on mechanical properties and chemical composition of bones in rats with ovariectomy-induced osteoporosis.Biomechanical properties of osteoporotic rat femurs after different hormonal treatments: genistein, estradiol, and estradiol/progesterone Genistein aglycone reverses glucocorticoid-induced osteoporosis and increases bone breaking strength in rats: a comparative study with alendronate Genistein inhibits osteoclastic differentiation of RAW 264.7 cells via regulation of ROS production and scavenging.An osteonecrosis model induced by oral bisphosphonate in ovariectomised rats.The steady-state serum concentration of genistein aglycone is affected by formulation: a bioequivalence study of bone products Additive effects of zoledronic acid and propranolol on bone density and biochemical markers of bone turnover in osteopenic ovariectomized rats.Mechanism of genistein regulating the differentiation of vascular smooth muscle cells into osteoblasts via the OPG/RANKL pathway.Raloxifene modulates regulators of osteoclastogenesis and angiogenesis in an oestrogen deficiency periapical lesion model.The Combination of icariin and constrained dynamic loading stimulation attenuates bone loss in ovariectomy-induced osteoporotic mice.Effects of different forages on the chemical compositions and antiosteoporotic activities of velvet antlers.Histomorphometric alteration of knee articular cartilage and serum alkaline phosphatase in young female mice by chronic supplementation with soybean.Soy protein improves tibial whole-bone and tissue-level biomechanical properties in ovariectomized and ovary-intact, low-fit female rats.

P2860

Q26801110-E40A4986-22E1-43AF-A9ED-AABF87D05A7F Q33567022-15B5E1E3-4BDB-482C-ADF5-6A4D9367438F Q33847745-88298156-1F96-4DFB-B1FE-484002715129 Q33859211-2743A449-FA86-4951-B11A-FA40E84573BD Q34113003-4E26910E-F77E-4982-8CF9-C48E8328623C Q34181031-3F76AB95-4B36-4238-A0E7-090BE6614529 Q34863980-AC863BB4-F704-41E4-A077-6A76483E80B8 Q35119637-FBEF45E8-A403-4E84-AEDA-FDDD987477E7 Q35155516-0ABBAF12-E2FE-4197-B516-E0D11F11E353 Q35164591-2E937C9F-D0E3-43E6-849F-3F55F8562E46 Q35234671-B25ABEA8-729B-431B-BC48-6BB75895F4E3 Q35646728-C999BD14-5A06-4598-85BD-466F96DE10DD Q35719196-078D0098-3FA5-4E95-BD0D-F5D68BBC60CB Q35853254-F23BF8AA-F3AB-478E-A061-56E7994D6E16 Q36088558-0BDCB099-277E-451B-807A-9B619F75168C Q36473950-9A399ABF-1B1B-42B0-902B-843FAC2EC08E Q36710262-34F0DAD3-A501-486E-8AB7-E5E84B06F2DA Q36733503-F23A061C-A702-4E4C-A388-A52B7A0EE122 Q36883244-2493510F-C000-4097-B6F0-23C6D39B5B3C Q36906317-040B731F-9B82-489E-9678-4DF5201A16AC Q37230770-B793A2F5-1618-4059-87DE-D0B77BA427C8 Q38985154-B730B4CF-EBDE-4C67-90C3-F635F5FCBC67 Q41019775-6997A040-E2DF-4023-A4C6-CDD6187C7204 Q41484340-C7B4F3EF-AA46-4848-98C9-34C5AF202344 Q41590774-6C275702-ABB7-4133-BC58-8A79278A92CF Q42908701-27437408-5585-487E-A496-CC23A937DA43 Q43987138-89A74D2A-8AFB-467B-8E7B-7EE47163AB15 Q47421375-8B992B98-42AD-401C-A2B8-B498AA471325 Q51321898-276CAEBD-F7B6-4659-BBA2-44A7A0C9FFD8 Q51531153-A6FFBCBA-B181-4902-8296-87934B019B9A Q55359589-CD862C55-1945-4E91-9A46-42EBF976FA2B

P2860

Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol.

http://www.wikidata.org/entity/Q33359381

description

2008 nî lūn-bûn

@nan

2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Effects of genistein aglycone ...... te, raloxifene and oestradiol.

@ast

Effects of genistein aglycone ...... te, raloxifene and oestradiol.

@en

type

label

Effects of genistein aglycone ...... te, raloxifene and oestradiol.

@ast

Effects of genistein aglycone ...... te, raloxifene and oestradiol.

@en

prefLabel

Effects of genistein aglycone ...... te, raloxifene and oestradiol.

@ast

Effects of genistein aglycone ...... te, raloxifene and oestradiol.

@en

P1433

Q33359381-6C6E5531-2F8B-4DEB-999B-A28496BBE0D6

P1476

Q33359381-31751171-F270-4608-8E96-983A6EE71710

P2093

Q33359381-0E52F3BD-8171-4247-873B-82A48AD24FD0

Q33359381-22A265CF-559E-4BFB-8E68-3E6AE4F7C8FD

Q33359381-39211A5D-634B-4168-89DB-2208EABCE26A

Q33359381-3C4050B7-5164-43E6-81CE-AFDCC74D5026

Q33359381-49EC6CE1-B79E-4C8A-B7A5-0C282EDD646D

Q33359381-5534AB59-7E03-4C6A-88C5-FE7701C1C74D

Q33359381-5D85174D-56B8-47F5-A03D-613AC8330C2C

Q33359381-68756FAF-50A5-48C9-9A56-54C6914E6AFF

Q33359381-C67972D4-6A3A-4F8E-9D96-B3351CC687C8

Q33359381-D3B9349F-A133-415E-91E7-705788CEA528

P2860

Q33359381-0B36199C-8CEE-4C0F-9786-724C7353B1F6

Q33359381-1228537E-1B79-448C-A132-047538DDFE62

Q33359381-175229DD-83EA-466B-A2B7-321C89EA938D

Q33359381-2751B493-4FCC-4BEC-BE23-8326C41C6709

Q33359381-2E8B3129-507B-400D-A683-FFAA994EE8F3

Q33359381-32F265BF-9540-498F-B055-FDD24341A95C

Q33359381-4648C64A-3C8B-48F8-B46F-D4C1F952E117

Q33359381-473902B5-85E8-4C03-802A-A131D0DBD4C4

Q33359381-4C36712C-73A2-4B5B-9880-792B95E69FF2

Q33359381-5322C88B-96E7-4846-9C89-F77C6A72973C

P304

Q33359381-3DA97D4B-AE81-4F4D-889F-59B7891F7F97

P31

Q33359381-0178D7EB-E59B-49D0-8648-8383D078EC8C

P356

Q33359381-6AF6AE63-1393-41D9-B39C-0513ED6E3F0E

P407

Q33359381-715B8769-C135-460E-8EC0-18A583A600F3

P433

Q33359381-827BC866-62B3-4212-B809-1A9F3095B2C7

P478

Q33359381-5FD59F7A-01F2-40A0-8F0C-7BA030E83110

P577

Q33359381-E8598191-E287-4AF8-B8BD-51758D114278

P5875

Q33359381-7A7C42B5-4101-47FA-A1F0-6AEFA3BAA51A

P698

Q33359381-4DCA085F-1992-4121-BC13-55A00B67CA22

P921

Q33359381-E9923067-F40A-4F1D-9684-97D4AD2AA270

P932

Q33359381-A16CBFA8-38F0-4B45-8676-A9188C68634D

P356

P1433

British Journal of Pharmacology

P1476

Effects of genistein aglycone ...... te, raloxifene and oestradiol.

@en

P2093

A Bitto

http://www.w3.org/2001/XMLSchema#string

B P Burnett

http://www.w3.org/2001/XMLSchema#string

D Altavilla

http://www.w3.org/2001/XMLSchema#string

F Polito

http://www.w3.org/2001/XMLSchema#string

F Squadrito

http://www.w3.org/2001/XMLSchema#string

H Marini

http://www.w3.org/2001/XMLSchema#string

L Minutoli

http://www.w3.org/2001/XMLSchema#string

M A Armbruster

http://www.w3.org/2001/XMLSchema#string

N Irrera

http://www.w3.org/2001/XMLSchema#string

R Granese

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta

Skeletal benefits of soy isoflavones: a review of the clinical trial and epidemiologic data.

Purified phytoestrogens in postmenopausal bone health: is there a role for genistein?

Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.

Estrogen receptor beta-selective transcriptional activity and recruitment of coregulators by phytoestrogens.

Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases.

P304

896-905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJP.2008.305

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23164242

http://www.w3.org/2001/XMLSchema#string

P698

18695641

http://www.w3.org/2001/XMLSchema#string

P921

P932

2515927

http://www.w3.org/2001/XMLSchema#string